Three COVID-19 Drugs Clear UK Funding Hurdle But Olumiant No Longer In The Running

NICE says it is the first health technology assessment body to look at the non-pandemic use of COVID-19 treatments. It is also planning to launch a consultation on a new process for updating its recommendations on such products with a view to making them available more quickly if new variants emerge.